Rockefeller Capital Management L.P. Dare Bioscience, Inc. Call Options Transaction History
Rockefeller Capital Management L.P.
- $34.7 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding DARE
# of Institutions
10Shares Held
813KCall Options Held
0Put Options Held
0-
State Street Corp Boston, MA282KShares$1.27 Million0.0% of portfolio
-
Black Rock Inc. New York, NY204KShares$916,3440.0% of portfolio
-
Two Sigma Securities, LLC New York, NY103KShares$463,0320.0% of portfolio
-
Ubs Group Ag99KShares$445,5720.0% of portfolio
-
Interwest Venture Management CO62.1KShares$279,2920.14% of portfolio
About Dare Bioscience, Inc.
- Ticker DARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,820,896
- Market Cap $382M
- Description
- Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...